Skip to main content
Earnings Labs
Autolus Therapeutics plc logo

Autolus Therapeutics plc (AUTL)

NASDAQ·Healthcare·Biotechnology

$1.94

-4.68%

Mkt Cap $431.15M

Analyst Ratings

Buy

3

Hold

0

Sell

0

Price Target (4 analysts)

$8.87

Range $7.60$11.00

Implied Upside

+358.4%

Consensus $8.87 vs current $1.94